Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04658368 · ClinicalTrials.gov registry record
Patient Reported Outcomes Following Targeted Muscle Reinnervation
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04658368 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 2 participants.
The verdict
NCT04658368 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and will complete a short electronic survey and option phone interview.
Interventions
- PROCEDURE Primary TMR
- PROCEDURE Secondary TMR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2022-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04658368
The ClinicalTrials.gov registry entry for NCT04658368 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Primary TMR is the first listed.
NCT04658368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04658368 about?
NCT04658368 is a clinical study titled "Patient Reported Outcomes Following Targeted Muscle Reinnervation". The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and...
What is the current status of trial NCT04658368?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2020-12-29. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04658368?
The interventions under investigation include: Primary TMR (PROCEDURE), Secondary TMR (PROCEDURE).
Who is sponsoring clinical trial NCT04658368?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.